Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linperlisib + Chidamide in R/R PTCL
NCT06083701Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linperlisib in peripheral T-cell lymphoma (PTCL), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
linperlisib
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT06083701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06083701.